Suppr超能文献

1型人类免疫缺陷病毒致病因子Nef的动态演变

Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

作者信息

O'Neill Eduardo, Kuo Lillian S, Krisko John F, Tomchick Diana R, Garcia J Victor, Foster John L

机构信息

Department of Internal Medicine, Division of Infectious Diseases Y9.206, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9113, USA.

出版信息

J Virol. 2006 Feb;80(3):1311-20. doi: 10.1128/JVI.80.3.1311-1320.2006.

Abstract

The human immunodeficiency virus type 1 (HIV-1) early gene product Nef is a multifunctional protein that alters numerous pathways of T-cell function, including endocytosis, signal transduction, vesicular trafficking, and immune modulation, and is a major determinant of pathogenesis. Individual Nef functions include PAK-2 activation, CD4 downregulation, major histocompatibility complex (MHC) class I downregulation, and enhancement of viral particle infectivity. How Nef accomplishes its multiple tasks presents a difficult problem of mechanistic analysis because of the complications associated with multiple, overlapping functional domains in the context of significant sequence variability. To address these issues we determined the conservation of each Nef residue based on 1,643 subtype B Nef sequences. Mutational analysis based on conservative substitutions and Nef sequence data allowed us to search for amino acids on the surface of Nef that are specifically required for PAK-2 activation. We found residues 85, 89, and 191 to be highly significant determinants for Nef's PAK-2 activation function but functionally unlinked to CD4 and MHC class I downregulation or enhancement of infectivity. These residues are not conserved across HIV-1 subtypes but are confined to separate sets of surface elements within a subtype. Thus, L85/H89/F191 and F85/F89/R191 are dominant in subtype B and subtype E or C, respectively. Our results provide support for developing subtype-specific interventions in HIV-1 disease.

摘要

1型人类免疫缺陷病毒(HIV-1)早期基因产物Nef是一种多功能蛋白,它能改变T细胞功能的众多途径,包括内吞作用、信号转导、囊泡运输和免疫调节,并且是发病机制的主要决定因素。Nef的个体功能包括激活PAK-2、下调CD4、下调主要组织相容性复合体(MHC)I类分子以及增强病毒颗粒的感染性。由于在显著的序列变异性背景下存在多个重叠功能域所带来的复杂性,Nef如何完成其多项任务提出了一个机械分析的难题。为了解决这些问题,我们基于1643个B亚型Nef序列确定了每个Nef残基的保守性。基于保守替换和Nef序列数据的突变分析使我们能够在Nef表面寻找PAK-2激活所特需的氨基酸。我们发现85、89和191位残基是Nef激活PAK-2功能的高度重要决定因素,但在功能上与CD4和MHC I类分子的下调或感染性增强无关。这些残基在HIV-1各亚型间并不保守,而是局限于一个亚型内不同的表面元件组中。因此,L85/H89/F191和F85/F89/R191分别在B亚型和E或C亚型中占主导地位。我们的结果为开发针对HIV-1疾病的亚型特异性干预措施提供了支持。

相似文献

1
Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.
J Virol. 2006 Feb;80(3):1311-20. doi: 10.1128/JVI.80.3.1311-1320.2006.
2
Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.
J Virol. 2001 Feb;75(4):1672-80. doi: 10.1128/JVI.75.4.1672-1680.2001.
3
Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts.
J Virol. 2004 Apr;78(8):4085-97. doi: 10.1128/jvi.78.8.4085-4097.2004.
4
Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele.
J Gen Virol. 2001 Nov;82(Pt 11):2735-2745. doi: 10.1099/0022-1317-82-11-2735.
9
Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.
Virology. 2006 Nov 25;355(2):175-91. doi: 10.1016/j.virol.2006.07.003. Epub 2006 Aug 17.

引用本文的文献

5
HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection.
Front Microbiol. 2019 Oct 30;10:2437. doi: 10.3389/fmicb.2019.02437. eCollection 2019.
6
Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.00719-19. Print 2019 Oct 15.
7
Weighted lambda superstrings applied to vaccine design.
PLoS One. 2019 Feb 8;14(2):e0211714. doi: 10.1371/journal.pone.0211714. eCollection 2019.
9
HIV-Nef Protein Persists in the Lungs of Aviremic Patients with HIV and Induces Endothelial Cell Death.
Am J Respir Cell Mol Biol. 2019 Mar;60(3):357-366. doi: 10.1165/rcmb.2018-0089OC.
10
Review of Current Cell-Penetrating Antibody Developments for HIV-1 Therapy.
Molecules. 2018 Feb 6;23(2):335. doi: 10.3390/molecules23020335.

本文引用的文献

3
The brightening future of HIV therapeutics.
Nat Immunol. 2004 Sep;5(9):867-71. doi: 10.1038/ni0904-867.
5
HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis.
PLoS Biol. 2004 Jan;2(1):E6. doi: 10.1371/journal.pbio.0020006. Epub 2004 Jan 20.
6
Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.
AIDS. 2003 Dec 5;17(18):2547-60. doi: 10.1097/01.aids.0000096895.73209.89.
8
HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway.
Cell. 2002 Dec 13;111(6):853-66. doi: 10.1016/s0092-8674(02)01162-5.
10
Nef: agent of cell subversion.
Microbes Infect. 2002 Feb;4(2):189-99. doi: 10.1016/s1286-4579(01)01527-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验